ALTIS BIOSYSTEMS
Biotechnology Research, 1289 Fordham Boulevard, Chapel Hill, North Carolina, 27514, United States, 11-50 Employees
Who is ALTIS BIOSYSTEMS
Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product is called RepliGut. It wil...
Read More
Get Full Access
-
Headquarters: 1289 Fordham Boulevard, Chapel Hill, North Carolina, 27514, United States
-
Date Founded: 2015
-
Employees: 11-50
-
Revenue: 5 Million to 10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology Research
SIC Code: 8731
|
NAICS Code: 541713 |
Show More
Does something look wrong? Fix it. | View contact records from ALTIS BIOSYSTEMS
View Employees
Email
Phone
Similar Companies to Altis Biosystems
Aileron Therapeutics
-
11-50
-
$ 5 Million to 10 Million
Altis Biosystems Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Altis Biosystems
Answer: Altis Biosystems's headquarters are located at 1289 Fordham Boulevard, Chapel Hill, North Carolina, 27514, United States
Answer: Altis Biosystems's official website is https://altisbiosystems.com
Answer: Altis Biosystems's revenue is 5 Million to 10 Million
Answer: Altis Biosystems's SIC: 8731
Answer: Altis Biosystems's NAICS: 541713
Answer: Altis Biosystems has 11-50 employees
Answer: Altis Biosystems is in BIOTECHNOLOGY RESEARCH
Answer: Altis Biosystems top competitors include: In8Bio, Dna Software, Dyve Biosciences, Amulet, Lynx Biosciences, Biomiga, Marin Biologic Laboratories, Syndevrx, Pbs Biotech, Gain Therapeutics, Aileron Therapeutics
Answer: Altis Biosystems contact info: Phone number: ********** Website: https://altisbiosystems.com
Answer: Altis has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. The product is called RepliGut. It will allow drugs to be tested on an in vitro platform that more closely mimics native human biology. Our goal is to enable pharmaceutical companies to identify effective compounds earlier, before clinical trials; to reduce animal testing; and to make the drug development process faster, cheaper, and safer. Currently, 88% of drugs fail during clinical trials. Part of the reason is that during preclinical studies, drugs are tested using tumor cells and animals. These cannot accurately indicate the way that pharmaceuticals will behave in the human body. The current market lacks a viable method for testing drugs, prior to human testing, and RepliGut will more accurately reflect drug behavior in humans.
Answer:
View Employees
Altis Biosystems Activity Score
Sign in to CIENCE GO Data to uncover contact details
Free credits every month